This index is defined as a combination of inflammatory markers such as C-reactive protein and neutrophil/lymphocyte ratio and is considered a potential tool for predicting clinical outcomes in a wide range of conditions from cancer to cardiovascular disease. Here, CRP is linked to cancer.